Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's initial focus is on advancing AV-101, its dry powder inhaled formulation of the drug imatinib for the treatment of pulmonary arterial hypertension, or PAH.
View Top Employees from Aerovate Therapeutics, Inc.| Website | http://aerovatetx.com |
| Employees | 47 (37 on RocketReach) |
| Founded | 2018 |
| Industry | Biotechnology, Drug Discovery, Pharmaceuticals |
Looking for a particular Aerovate Therapeutics, Inc. employee's phone or email?
Aerovate Therapeutics, Inc. Questions
George Eldridge is the CFO of Aerovate Therapeutics, Inc..
37 people are employed at Aerovate Therapeutics, Inc..
Aerovate Therapeutics, Inc. is based in Boston, Massachusetts.
Top Aerovate Therapeutics, Inc. Employees
-
13
-
24
-
55+
-
5+5+
-
ViewSue Fischer
Senior Vice President Development Operations at Aerovate Therapeutics, Inc.
Marshfield, MA, US33 -
54
-
32
-
1
-
31
Related Companies
